Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
1999 Oct 12;9621:12162-7. doi: 10.1073/pnas.96.21.12162.
Show Gene links
Show Anatomy links
Pharmacological plasticity of cardiac ATP-sensitive potassium channels toward diazoxide revealed by ADP.
D'hahan N
,
Moreau C
,
Prost AL
,
Jacquet H
,
Alekseev AE
,
Terzic A
,
Vivaudou M
.
???displayArticle.abstract???
The pharmacological phenotype of ATP-sensitive potassium (K(ATP)) channels is defined by their tissue-specific regulatory subunit, the sulfonylurea receptor (SUR), which associates with the pore-forming channel core, Kir6.2. The potassium channel opener diazoxide has hyperglycemic and hypotensive properties that stem from its ability to open K(ATP) channels in pancreas and smooth muscle. Diazoxide is believed not to have any significant action on cardiac sarcolemmal K(ATP) channels. Yet, diazoxide can be cardioprotective in ischemia and has been found to bind to the presumed cardiac sarcolemmal K(ATP) channel-regulatory subunit, SUR2A. Here, in excised patches, diazoxide (300 microM) activated pancreatic SUR1/Kir6.2 currents and had little effect on native or recombinant cardiac SUR2A/Kir6.2 currents. However, in the presence of cytoplasmic ADP (100 microM), SUR2A/Kir6.2 channels became as sensitive to diazoxide as SUR1/Kir6. 2 channels. This effect involved specific interactions between MgADP and SUR, as it required Mg(2+), but not ATP, and was abolished by point mutations in the second nucleotide-binding domain of SUR, which impaired channel activation by MgADP. At the whole-cell level, in cardiomyocytes treated with oligomycin to block mitochondrial function, diazoxide could also activate K(ATP) currents only after cytosolic ADP had been raised by a creatine kinase inhibitor. Thus, ADP serves as a cofactor to define the responsiveness of cardiac K(ATP) channels toward diazoxide. The present demonstration of a pharmacological plasticity of K(ATP) channels identifies a mechanism for the control of channel activity in cardiac cells depending on the cellular ADP levels, which are elevated under ischemia.
Aguilar-Bryan,
Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion.
1995, Pubmed
Aguilar-Bryan,
Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion.
1995,
Pubmed
Aguilar-Bryan,
Toward understanding the assembly and structure of KATP channels.
1998,
Pubmed
Alekseev,
Ligand-insensitive state of cardiac ATP-sensitive K+ channels. Basis for channel opening.
1998,
Pubmed
Babenko,
Reconstituted human cardiac KATP channels: functional identity with the native channels from the sarcolemma of human ventricular cells.
1998,
Pubmed
Brady,
Operative condition-dependent response of cardiac ATP-sensitive K+ channels toward sulfonylureas.
1998,
Pubmed
Ciampolillo,
Effects of diazoxide and glyburide on ATP-sensitive K+ channels from hypertrophied ventricular myocytes.
1992,
Pubmed
D'hahan,
A transmembrane domain of the sulfonylurea receptor mediates activation of ATP-sensitive K(+) channels by K(+) channel openers.
1999,
Pubmed
,
Xenbase
Dzeja,
Phosphotransfer reactions in the regulation of ATP-sensitive K+ channels.
1998,
Pubmed
Dzeja,
Adenylate kinase-catalyzed phosphotransfer in the myocardium : increased contribution in heart failure.
1999,
Pubmed
Faivre,
Effects of tolbutamide, glibenclamide and diazoxide upon action potentials recorded from rat ventricular muscle.
1989,
Pubmed
Forestier,
Mechanism of action of K channel openers on skeletal muscle KATP channels. Interactions with nucleotides and protons.
1996,
Pubmed
Garlid,
Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection.
1997,
Pubmed
Gribble,
The essential role of the Walker A motifs of SUR1 in K-ATP channel activation by Mg-ADP and diazoxide.
1997,
Pubmed
,
Xenbase
Hamill,
Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.
1981,
Pubmed
Higgins,
ABC transporters: from microorganisms to man.
1992,
Pubmed
Holmuhamedov,
ATP-sensitive K+ channel openers prevent Ca2+ overload in rat cardiac mitochondria.
1999,
Pubmed
Holmuhamedov,
Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function.
1998,
Pubmed
Hung,
Crystal structure of the ATP-binding subunit of an ABC transporter.
1998,
Pubmed
Inagaki,
Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor.
1995,
Pubmed
Inagaki,
A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels.
1996,
Pubmed
Isomoto,
A novel sulfonylurea receptor forms with BIR (Kir6.2) a smooth muscle type ATP-sensitive K+ channel.
1996,
Pubmed
Isomoto,
Function, regulation, pharmacology, and molecular structure of ATP-sensitive K+ channels in the cardiovascular system.
1997,
Pubmed
Jahangir,
Intracellular acidification and ADP enhance nicorandil induction of ATP sensitive potassium channel current in cardiomyocytes.
1994,
Pubmed
Jovanovic,
Diadenosine polyphosphate-induced inhibition of cardiac KATP channels: operative state-dependent regulation by a nucleoside diphosphate.
1996,
Pubmed
Liman,
Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs.
1992,
Pubmed
,
Xenbase
Liu,
Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection?
1998,
Pubmed
Lorenz,
Evidence for direct physical association between a K+ channel (Kir6.2) and an ATP-binding cassette protein (SUR1) which affects cellular distribution and kinetic behavior of an ATP-sensitive K+ channel.
1998,
Pubmed
Lorenz,
Physical association between recombinant cardiac ATP-sensitive K+ channel subunits Kir6.2 and SUR2A.
1999,
Pubmed
Okuyama,
The effects of nucleotides and potassium channel openers on the SUR2A/Kir6.2 complex K+ channel expressed in a mammalian cell line, HEK293T cells.
1998,
Pubmed
Paulissian,
Diazoxide.
1978,
Pubmed
Radda,
The use of NMR spectroscopy for the understanding of disease.
1986,
Pubmed
Sato,
Cibenzoline inhibits diazoxide- and 2,4-dinitrophenol-activated ATP-sensitive K+ channels in guinea-pig ventricular cells.
1993,
Pubmed
Schwanstecher,
Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
1998,
Pubmed
Seino,
ATP-sensitive potassium channels: a model of heteromultimeric potassium channel/receptor assemblies.
1999,
Pubmed
Shyng,
Regulation of KATP channel activity by diazoxide and MgADP. Distinct functions of the two nucleotide binding folds of the sulfonylurea receptor.
1997,
Pubmed
Standen,
Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle.
1989,
Pubmed
Terzic,
Dualistic behavior of ATP-sensitive K+ channels toward intracellular nucleoside diphosphates.
1994,
Pubmed
Trube,
Opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic beta-cells.
1986,
Pubmed
Tucker,
Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor.
1997,
Pubmed
,
Xenbase
Ueda,
MgADP antagonism to Mg2+-independent ATP binding of the sulfonylurea receptor SUR1.
1997,
Pubmed
Venkatesh,
Sulfonylureas, ATP-sensitive K+ channels, and cellular K+ loss during hypoxia, ischemia, and metabolic inhibition in mammalian ventricle.
1991,
Pubmed
Vivaudou,
Modification by protons of frog skeletal muscle KATP channels: effects on ion conduction and nucleotide inhibition.
1995,
Pubmed
